Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1994 | 1 |
2006 | 1 |
2014 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
The following terms were ignored: %, %, %, %
The following terms were not found in PubMed: 22Gadolinium, 5BMAJR
Page 1
Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.
Hepatol Int. 2015 Apr;9(2):303-9. doi: 10.1007/s12072-014-9595-8. Epub 2014 Dec 6.
Hepatol Int. 2015.
PMID: 25788184
OBJECTIVES: The aim of this study was to evaluate the potential of gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI for assessment of bile duct ligation (BDL)-induced chelostatic liver injury in an animal model by T1 relaxation time measurements and first-pass perfusion an …
OBJECTIVES: The aim of this study was to evaluate the potential of gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI for assessment of …
The differences in the T2 relaxation rates of the protons in the partially-deuteriated and fully protonated sugar residues in a large oligo-DNA ('NMR-window') gives complementary structural information.
Agback P, Maltseva TV, Yamakage SI, Nilson FP, Földesi A, Chattopadhyaya J.
Agback P, et al.
Nucleic Acids Res. 1994 Apr 25;22(8):1404-12. doi: 10.1093/nar/22.8.1404.
Nucleic Acids Res. 1994.
PMID: 8190632
Free PMC article.
Item in Clipboard
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Ferrer L, Faivre-Chauvet A, Campion L, Vuillez JP, Devillers A, Chang CH, Goldenberg DM, Chatal JF, Barbet J.
Kraeber-Bodéré F, et al.
J Nucl Med. 2006 Feb;47(2):247-55.
J Nucl Med. 2006.
PMID: 16455630
Free article.
Clinical Trial.
Safety, targeting, and antitumor efficacy of pretargeted radioimmunotherapy using anti-carcinoembryonic antigen (CEA) hMN-14 x m734 bispecific antibody (BsmAb) and 131I-di-diethylenetriamine pentaacetic acid (DTPA)-indium hapten were evaluated in a phase I study per …
Safety, targeting, and antitumor efficacy of pretargeted radioimmunotherapy using anti-carcinoembryonic antigen (CEA) hMN-14 x m734 bispecif …
Item in Clipboard
Cite
Cite